(Q38068491)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Bringing cancer serological diagnosis to a new level: focusing on HER2, protein ectodomain shedding and neoepitope technology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Jianxia Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Qinlong Zheng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Ying Xue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Morten A Karsdal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Anne C Bay-Jensen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

language of work or name

English

0 references

publication date

1 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

35-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

Biomarkers in cancer staging, prognosis and treatment selection

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Breast cancer - one term, many entities?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Impact of biomarkers on clinical trial risk in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Potential Clinical Utility of Serum HER-2/neu Oncoprotein Concentrations in Patients with Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

HER-2/neu diagnostics in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

HER2 shedding and serum HER2 extracellular domain: biology and clinical utility in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

The biology of erbB-2/neu/HER-2 and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

The human splice variant Δ16HER2 induces rapid tumor onset in a reporter transgenic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

ADAMs in cancer cell proliferation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Value and limitations of measuring HER-2 extracellular domain in the serum of breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

A molecular view of anti-ErbB monoclonal antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Shed HER2 extracellular domain in HER2-mediated tumor growth and in trastuzumab susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Lapatinib for advanced or metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Lapatinib, a dual HER1/HER2 tyrosine kinase inhibitor, augments basal cleavage of HER2 extracellular domain (ECD) to inhibit HER2-driven cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Role of exon-16-deleted HER2 in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

An oncogenic isoform of HER2 associated with locally disseminated breast cancer and trastuzumab resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Novel combinations of Post-Translational Modification (PTM) neo-epitopes provide tissue-specific biochemical markers--are they the cause or the consequence of the disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Cartilage formation measured by a novel PIINP assay suggests that IGF-I does not stimulate but maintains cartilage formation ex vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Application of biochemical markers in development of drugs for treatment of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Biochemical markers of joint tissue turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Proteolytic networks in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Structure, function and pathophysiology of protease activated receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Cancer cells cut homophilic cell adhesion molecules and run

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Assessment of proteolytic degradation of the basement membrane: a fragment of type IV collagen as a biochemical marker for liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

MMP mediated degradation of type VI collagen is highly associated with liver fibrosis--identification and validation of a novel biochemical marker assay

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Procollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Immunological detection of the type V collagen propeptide fragment, PVCP-1230, in connective tissue remodeling associated with liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.12.161

21 January 2018

Identifiers

DOI

10.2217/FON.12.161

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23252562%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference